RIFAMYCIN vs RIPRETINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
RIFAMYCIN vs RIPRETINIB: Safety Overview
| Metric | RIFAMYCIN | RIPRETINIB |
|---|---|---|
| Total FAERS Reports | 106 | 4,432 |
| Deaths Reported | 26 | 465 |
| Death Rate | 24.5% | 10.5% |
| Hospitalizations | 35 | 948 |
| Average Patient Age | 56.1 yrs | 66.8 yrs |
| % Female Patients | 54.5% | 45.3% |
| FDA Approval Date | Nov 16, 2018 | May 15, 2020 |
| Manufacturer | N/A | Deciphera Pharmaceuticals, LLC |
| Route | N/A | ORAL |
| Marketing Status | Discontinued | Prescription |